Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read More

Top Stories

AI in Medical Affairs & Medical Communications

Science, AI, and Human Ingenuity Converge to

Today, we're witnessing an unprecedented convergence of...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Caregivers, Clinical Trials, Global Pharma, Health Outcomes, Patient Advocacy, Patient Centricity, patient communication, Patient Engagement, Patient Inclusion, Patient Participation

Improving Health Outcomes by Empowering Patients: The Future Is Here

Empowering patients and involving them as key stakeholders in the drug development lifecycle can help...

Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward

Ensuring that your organization embraces DE & I training is important for cultivating a strong...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
man reviewing clinical data, current treatments, economic data, product information, and data on burden of disease

HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats

Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Medical device regulation and how the safety, performance, and RMS align

Simple Considerations before Determining S&P Objectives for Medical Devices

With all the things to consider with Medical Device Regulations, it's important to identify the...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

Learn more ABOUT our company.